Acquisition Announced

XRA 7 Corp. acquisition of Generation Bio Co.

Announced 15 Dec 2025 · US$4.29 cash and scrip per share

Advisers

Generation Bio Co.

Target

Financial adviser
TD Securities (as TD Cowen)
Legal adviser
Fairness opinion
TD Securities (as TD Cowen)

XRA 7 Corp.

Acquirer

Legal adviser
Target
Generation Bio Co.
Acquirer
XRA 7 Corp.
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Life Sciences

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.